Cargando…
ORAL ANTICOAGULATION IN HOSPITALIZED PATIENTS WITH COVID-19, IS IT BENEFICIAL OR HARMFUL ?
Autores principales: | Gade, Akhil Reddy, Bailey, Som Aftabi, Subramanian, Anand, Salagundla, Nethuja, Ashangari, Chandralekha, Haci, Seline, Thambidorai, Senthil, Mundluru, Giridhar D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972451/ http://dx.doi.org/10.1016/S0735-1097(22)03151-5 |
Ejemplares similares
-
ATRIAL ARRHYTHMIAS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19
por: Bailey, Som Aftabi, et al.
Publicado: (2021) -
EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
por: Patel, Aman, et al.
Publicado: (2022) -
SYSTEMATIC REVIEW AND META-ANALYSIS OF REMDESIVIR AND BRADYCARDIA IN PATIENTS WITH COVID-19
por: Jipescu, Daniel, et al.
Publicado: (2022) -
CARDIAC MAGNETIC RESONANCE (CMR) FINDINGS IN PATIENTS WITH ACUTE MYOCARDITIS AFTER RECEIVING THE SECOND DOSE OF COVID19 MRNA VACCINE: A SYSTEMATIC REVIEW
por: Alatta, Lina, et al.
Publicado: (2022) -
A SYSTEMATIC REVIEW ON ECHOCARDIOGRAPHIC FINDINGS OF MYOCARDITIS AFTER THE SECOND COVID-19 MRNA VACCINATION DOSE
por: Elsayed, Sarah, et al.
Publicado: (2022)